MILabs B.V. (Molecular Imaging Labs) provides high-end molecular imaging PET, SPECT, CT and optical instruments for biomedical research. Today these hybrid systems contribute worldwide to the development of new diagnostic solutions and therapies for diseases such as diabetes, cancer, cardiac and neurodegenerative diseases. Based on its preclinical success with MILabs proprietary U-SPECT technology, the G-SPECT system was developed. This clinical SPECT scanner received the 2015 Innovation of the Year award from the World Molecular Imaging Society. The ten-fold volumetric resolution improvement provides an image quality to visualize much smaller lesions than was possible before, which adds diagnostic confidence and accurate quantitative measurements to nuclear medicine imaging.

MILabs is delivering worldwide to renowned research institutions and hospitals.